Prediction of the solubility in lipidic solvent mixture: Investigation of the modeling approach and thermodynamic analysis of solubility.

Self-micro emulsifying drug delivery system (SMEDDS) is one of the methods to improve solubility and bioavailability of poorly soluble drug(s). The knowledge of the solubility of pharmaceuticals in pure lipidic solvents and solvent mixtures is crucial for designing the SMEDDS of poorly soluble drug substances. Since, experiments are very time consuming, a model, which allows for solubility predictions in solvent mixtures based on less experimental data is desirable for efficiency. Solvents employed were Labrafil® M1944CS and Labrasol® as lipidic solvents; Capryol-90®, Capryol-PGMC® and Tween®-80 as surfactants; Transcutol® and PEG-400 as co-solvents. Solubilities of both drugs were determined in single solvent systems at temperature (T) range of 283-333K. In present study, we investigated the applicability of the thermodynamic model to understand the solubility behavior of drugs in the lipiodic solvents. By using the Van't Hoff and general solubility theory, the thermodynamic functions like Gibbs free energy, enthalpy and entropy of solution, mixing and solvation for drug in single and mixed solvents were understood. The thermodynamic parameters were understood in the framework of drug-solvent interaction based on their chemical similarity and dissimilarity. Clotrimazole and Fluconazole were used as active ingredients whose solubility was measured in single solvent as a function of temperature and the data obtained were used to derive mathematical models which can predict solubility in multi-component solvent mixtures. Model dependent parameters for each drug were calculated at each temperature. The experimental solubility data of solute in mixed solvent system were measured experimentally and further correlated with the calculates values obtained from exponent model and log-linear model of Yalkowsky. The good correlation was observed between experimental solubility and predicted solubility.

[1]  K. Tochigi,et al.  Prediction of solubilities of pharmaceutical compounds in water + co-solvent systems using an activity coefficient model , 2010 .

[2]  C. Eckert,et al.  Generalized reference fugacities for phase equilibrium thermodynamics , 1965 .

[3]  Christel A. S. Bergström,et al.  Poorly soluble marketed drugs display solvation limited solubility. , 2007, Journal of medicinal chemistry.

[4]  G. Gupta,et al.  Solubility Enhancement – Eminent Role in Poorly Soluble Drugs , 2009 .

[5]  David J.W. Grant,et al.  Solubility behavior of organic compounds , 1990 .

[6]  S. Rohani,et al.  Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms. , 2004, International journal of pharmaceutics.

[7]  Abolghasem Jouyban,et al.  Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures. , 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[8]  Christopher J H Porter,et al.  Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.

[9]  J. Prausnitz,et al.  Regular and related solutions : the solubility of gases, liquids, and solids , 1970 .

[10]  Colin W. Pouton,et al.  Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound , 2004, Pharmaceutical Research.

[11]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[12]  A. Fahr,et al.  Drug delivery strategies for poorly water-soluble drugs , 2007, Expert opinion on drug delivery.

[13]  Abolghasem Jouyban,et al.  Handbook of Solubility Data for Pharmaceuticals , 2009 .

[14]  C. Porter,et al.  In vitro assessment of oral lipid based formulations. , 2001, Advanced drug delivery reviews.

[15]  Tonglei Li,et al.  Analysis of Relationships Between Solid-State Properties, Counterion, and Developability of Pharmaceutical Salts , 2010, AAPS PharmSciTech.

[16]  G. Hefter,et al.  The experimental determination of solubilities , 2004 .

[17]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  E. Macedo,et al.  Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  N. Garti,et al.  Improved solubilization of Celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution. , 2006, Journal of colloid and interface science.

[20]  A. Bauer-Brandl,et al.  Towards an understanding of the molecular mechanism of solvation of drug molecules: a thermodynamic approach by crystal lattice energy, sublimation, and solubility exemplified by paracetamol, acetanilide, and phenacetin. , 2006, Journal of pharmaceutical sciences.

[21]  T. Mahmood,et al.  Basics of Self Micro Emulsifying Drug Delivery System , 2012 .

[22]  N. Garti,et al.  Self-diffusion nuclear magnetic resonance, microstructure transitions, and solubilization capacity of phytosterols and cholesterol in Winsor IV food-grade microemulsions. , 2003, Journal of Agricultural and Food Chemistry.

[23]  N. Garti,et al.  Solubilization patterns of lutein and lutein esters in food grade nonionic microemulsions. , 2003, Journal of agricultural and food chemistry.

[24]  Christel A. S. Bergström,et al.  Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients , 2013, Pharmaceutical Research.

[25]  M. Abraham,et al.  Mathematical correlation of salicylamide solubilities in organic solvents with the Abraham solvation parameter model , 2004 .

[26]  Thorsteinn Loftsson,et al.  Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.

[27]  M. Alam,et al.  Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updates , 2012, Expert opinion on drug delivery.

[28]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[29]  Jinming Gao,et al.  Nanonization strategies for poorly water-soluble drugs. , 2011, Drug discovery today.

[30]  F. Martínez,et al.  Thermodynamic analysis and enthalpy―entropy compensation for the solubility of indomethacin in aqueous and non-aqueous mixtures , 2011 .

[31]  Jignasa K. Savjani,et al.  Drug Solubility: Importance and Enhancement Techniques , 2012, ISRN pharmaceutics.

[32]  Fariba Dehghani,et al.  Micronization by Rapid Expansion of Supercritical Solutions to Enhance the Dissolution Rates of Poorly Water-Soluble Pharmaceuticals , 2000 .

[33]  E. Baum.  Chemical Property Estimation: Theory and Application , 1997 .

[34]  I. Miroshnyk,et al.  Pharmaceutical co-crystals–an opportunity for drug product enhancement , 2009, Expert opinion on drug delivery.

[35]  Jeffrey Millard,et al.  Solubilization by cosolvents. Establishing useful constants for the log-linear model. , 2002, International journal of pharmaceutics.

[36]  S. Benita,et al.  Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  J. Gong,et al.  Correlation of Solubility and Prediction of the Mixing Properties of Ginsenoside Compound K in Various Solvents , 2012 .

[38]  M. Tissandier,et al.  The Proton's Absolute Aqueous Enthalpy and Gibbs Free Energy of Solvation from Cluster-Ion Solvation Data , 1998 .

[39]  Qiang Fu,et al.  Determination of the solubility, dissolution enthalpy and entropy of icariin in water, ethanol, and methanol , 2012 .

[40]  P. Roberts,et al.  Effects of solute concentration and cosolvents on the aqueous activity coefficient of halogenated hydrocarbons. , 1986, Environmental science & technology.

[41]  P. Constantinides,et al.  Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects , 1995, Pharmaceutical Research.

[42]  Hywel D Williams,et al.  Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.

[43]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[44]  Ning Shan,et al.  The role of cocrystals in pharmaceutical science. , 2008, Drug discovery today.

[45]  A. Fahr,et al.  Drug Delivery Strategies for Poorly Water-Soluble Drugs: Douroumis/Drug , 2013 .

[46]  G. Liversidge,et al.  Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .

[47]  Steven W. Booth,et al.  An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy , 1995 .

[48]  S. Rohani,et al.  Optimal Solvent Screening for the Crystallization of Pharmaceutical Compounds from Multisolvent Systems , 2012 .

[49]  H. Hao,et al.  Determination of the Solubility, Dissolution Enthalpy, and Entropy of Pioglitazone Hydrochloride (Form II) in Different Pure Solvents , 2013 .

[50]  P York,et al.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. , 2007, Advanced drug delivery reviews.

[51]  Peter A. Crafts,et al.  Correlation and Prediction of Drug Molecule Solubility in Mixed Solvent Systems with the Nonrandom Two-Liquid Segment Activity Coefficient (NRTL−SAC) Model , 2006 .

[52]  A. Bauer-Brandl,et al.  Thermodynamic properties of flufenamic and niflumic acids--specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution. , 2007, Journal of pharmaceutical and biomedical analysis.

[53]  Jeong-Sook Park,et al.  Solubility enhancers for oral drug delivery , 2004 .

[54]  J. Gong,et al.  Measurement and Correlation of Solubility of Clopidogrel Hydrogen Sulfate (Metastable Form) in Lower Alcohols , 2011 .

[55]  Arik Dahan,et al.  Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.

[57]  G. Murtaza,et al.  Comparative evaluation of various solubility enhancement strategies for furosemide. , 2014, Pakistan journal of pharmaceutical sciences.

[58]  Bradley D Anderson,et al.  What determines drug solubility in lipid vehicles: is it predictable? , 2008, Advanced drug delivery reviews.

[59]  Gabriele Sadowski,et al.  Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design. , 2009, Journal of pharmaceutical sciences.

[60]  P. Sharma,et al.  Self Emulsifying Drug Delivery System (SEDDS): a Review , 2014 .

[61]  M. Khan,et al.  Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. , 2001, International journal of pharmaceutics.

[62]  P. Gao,et al.  Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs , 2006, Expert opinion on drug delivery.